A new drug derived from marijuana has led to a landmark change in the US government's stance on cannabis.

After being greenlit as the first federally approved cannabis-based medication at the end of June, the drug has triggered the nation's top drug enforcer to change how it regulates marijuana.

It's the first time in 46 years that the agency has shifted its stance on a marijuana compound.

The drug, Epidiolex, is designed to treat two rare forms of childhood epilepsy using cannabidiol, or CBD, the compound in marijuana not responsible for a high. 

Click here to read the complete article

Erin Brodwin ~ BusinessInsider.com

Recent News Articles

Thursday January 23

Pennsylvania’s medical marijuana program faces persistent pot shortages - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

Pennsylvania doesn’t have enough marijuana to go around.

2203 hits

Thursday January 23

Medical and recreational marijuana may be legal in some states, but not always at airport…

in Travel

by Bruce Kennedy - Editor in Chief

With more and more states legalizing recreational and medical marijuana, what are the rules when…

2182 hits

Thursday January 23

Kentucky will continue hemp program as pilot for a year - Cannabis News

in CBD & Hemp

by Bruce Kennedy - Editor in Chief

Kentucky’s Department of Agriculture will continue operating its hemp program as a research pilot program…

2632 hits

Friday January 24

Oklahoma medical marijuana numbers soar past other states - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

As the Oklahoma medical marijuana industry enters its second full year since legalization, the numbers…

2243 hits

Friday January 24

Farmers Look Back on Colorado's First Six Years of Hemp - Cannabis News

in CBD & Hemp

by Bruce Kennedy - Editor in Chief

In Colorado, hemp has gone through an evolution similar to that of recreational cannabis, with…

2162 hits